Literature DB >> 19733181

Adenosine deaminase ADAR1 increases gene expression at the translational level by decreasing protein kinase PKR-dependent eIF-2alpha phosphorylation.

Ying Wang1, Charles E Samuel.   

Abstract

ADAR1 (adenosine deaminase acting on RNA) catalyzes the deamination of adenosine to inosine on RNA substrates with double-stranded character. Here, we show that coexpression of ADAR1 in mammalian cells markedly increases plasmid-based gene expression in transfected cells. The enhanced expression was independent of the nature of the promoter (viral and cellular) used to drive gene expression, of the protein reporter (luciferase and RRP) tested, and of the human cell line examined (293T and HeLa). Exogenous protein levels were increased by approximately 20-fold to approximately 50-fold when ADAR1 was coexpressed, whereas RNA transcript levels changed by less than 2-fold. The activation of PKR (protein kinase regulated by RNA) protein kinase and the phosphorylation of translation initiation factor eIF-2alpha seen following plasmid DNA transfection were both greatly reduced in ADAR1-transfected cells. Stable knockdown of the PKR kinase increased reporter gene expression in the absence, but not in the presence, of ADAR1 coexpression. Both size forms of ADAR1-the p150-inducible form and the p110-like constitutive form-enhanced plasmid-based gene expression. Taken together, these results indicate that the ADAR1 deaminase increases exogenous gene expression at the translational level by decreasing PKR-dependent eIF-2alpha phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19733181      PMCID: PMC2763985          DOI: 10.1016/j.jmb.2009.08.070

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  58 in total

1.  The antiviral enzymes PKR and RNase L suppress gene expression from viral and non-viral based vectors.

Authors:  F Terenzi; M J deVeer; H Ying; N P Restifo; B R Williams; R H Silverman
Journal:  Nucleic Acids Res       Date:  1999-11-15       Impact factor: 16.971

Review 2.  Gene-specific regulation by general translation factors.

Authors:  Thomas E Dever
Journal:  Cell       Date:  2002-02-22       Impact factor: 41.582

Review 3.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

4.  PACT-mediated enhancement of reporter gene expression at the translational level.

Authors:  Shoudong Li; Ganes C Sen
Journal:  J Interferon Cytokine Res       Date:  2003-12       Impact factor: 2.607

5.  RNA editing minireview series.

Authors:  Charles E Samuel
Journal:  J Biol Chem       Date:  2002-11-20       Impact factor: 5.157

6.  RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway.

Authors:  Yu-Hsin Chiu; John B Macmillan; Zhijian J Chen
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

7.  Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  Regulated translation initiation controls stress-induced gene expression in mammalian cells.

Authors:  H P Harding; I Novoa; Y Zhang; H Zeng; R Wek; M Schapira; D Ron
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

Review 9.  Cationic lipid-DNA complexes for gene therapy: understanding the relationship between complex structure and gene delivery pathways at the molecular level.

Authors:  Kai Ewert; Nelle L Slack; Ayesha Ahmad; Heather M Evans; Alison J Lin; Charles E Samuel; Cyrus R Safinya
Journal:  Curr Med Chem       Date:  2004-01       Impact factor: 4.530

10.  In vivo effects of the Epstein-Barr virus small RNA EBER-1 on protein synthesis and cell growth regulation.

Authors:  Kenneth G Laing; Androulla Elia; Ian Jeffrey; Volker Matys; Vivienne J Tilleray; Bernard Souberbielle; Michael J Clemens
Journal:  Virology       Date:  2002-06-05       Impact factor: 3.616

View more
  23 in total

Review 1.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

Review 2.  Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase.

Authors:  Jean-François Gélinas; Guerline Clerzius; Eileen Shaw; Anne Gatignol
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

Review 3.  ADARs: viruses and innate immunity.

Authors:  Charles E Samuel
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 4.  Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses.

Authors:  Charles E Samuel
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

5.  Protein kinase PKR catalytic activity is required for the PKR-dependent activation of mitogen-activated protein kinases and amplification of interferon beta induction following virus infection.

Authors:  Nora Taghavi; Charles E Samuel
Journal:  Virology       Date:  2012-03-03       Impact factor: 3.616

6.  Reovirus-mediated induction of ADAR1 (p150) minimally alters RNA editing patterns in discrete brain regions.

Authors:  Jennifer L Hood; Michael V Morabito; Charles R Martinez; James A Gilbert; Elizabeth A Ferrick; Gregory D Ayers; James D Chappell; Terence S Dermody; Ronald B Emeson
Journal:  Mol Cell Neurosci       Date:  2014-06-04       Impact factor: 4.314

Review 7.  ADAR editing in double-stranded UTRs and other noncoding RNA sequences.

Authors:  Heather A Hundley; Brenda L Bass
Journal:  Trends Biochem Sci       Date:  2010-04-08       Impact factor: 13.807

Review 8.  Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response.

Authors:  Christian K Pfaller; Zhiqun Li; Cyril X George; Charles E Samuel
Journal:  Curr Opin Immunol       Date:  2011-09-15       Impact factor: 7.486

9.  Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1.

Authors:  Nga Ling Ko; Emmanuel Birlouez; Simon Wain-Hobson; Renaud Mahieux; Jean-Pierre Vartanian
Journal:  J Gen Virol       Date:  2012-09-19       Impact factor: 3.891

10.  RNA-dependent protein kinase PKR and the Z-DNA binding orthologue PKZ differ in their capacity to mediate initiation factor eIF2α-dependent inhibition of protein synthesis and virus-induced stress granule formation.

Authors:  Nora Taghavi; Charles E Samuel
Journal:  Virology       Date:  2013-05-23       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.